Unravelling cell biology through artificial intelligence
The AI algorithm was able to predict the presence and the location of nuclei in more than 8,000 cells.
List view / Grid view
The AI algorithm was able to predict the presence and the location of nuclei in more than 8,000 cells.
Researchers found that fibroblasts had varying effects on tumour cells based on both the type of non-small cell lung cancer and the drug used for treatment.
A novel peptide augments the brain’s natural mechanism to help prevent seizures and protect neurons in research models of both Alzheimer’s and epilepsy.
Researchers have developed an mRNA-based cancer vaccine that is delivered directly into the lymphatic system for a more potent response.
Scientists develop a novel single-cell proteomics technique based on water droplet-in-oil digestion to enable efficient protein recovery.
Researchers have developed a machine learning method to quantitatively analyse and compare microscopy images of proteins.
Researchers have discovered that “jumping gene” Lx9c11 has a profound effect on the immune system to virus infection.
12 August 2022 | By
A new technique could relieve pain for individuals with various chronic and neurological conditions.
Researchers have developed a needle-free mucosal bacteriophage (phage) T4-based COVID-19 vaccine is effective against SARS-CoV-2 infection.
Using computational methods, researchers analysed the most popular CRISPR library designed for human cells and found 3,300 targeted spots that show strong toxic effects.
An in-silico reaction screening strategy could produce compounds potentially useful for novel drug development.
The researchers identified key molecular differences between triple-negative breast cancer cells that cling to an initial tumour and those that venture off to form distant tumours.
Researchers have gained a clearer understanding of the genetic and molecular machinery in human microglia, findings that may provide insight into Alzheimer’s diseases development.
The vaccine attaches spike proteins from SARS-CoV-2 and seven other SARS-like betacoronaviruses to a protein nanoparticle structure, to induce the production of a broad spectrum of cross-reactive antibodies.
Scientists have identified a molecule that can bind to a lethal subtype of the bacterial Shiga toxin, suppressing its deadly effects.